Sitagliptin Defuoro IMpurity 5 CAS：486460-31-5

2025-3-25

Product Overview

This article provides a comprehensive guide to Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5, a crucial component in the pharmaceutical industry. It covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. This guide aims to assist users in understanding the product better and making informed decisions.

Abstract

This article offers an in-depth analysis of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5, a key ingredient in the pharmaceutical industry. It discusses its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. The guide aims to provide users with a comprehensive understanding of the product and assist them in making informed decisions.

Product Parameters

Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is a white to off-white crystalline powder with a melting point of 234-238°C. It has a molecular weight of 415.48 g/mol and a molecular formula of C₂₆H₃₈N₄O₅. The product is highly pure, with a minimum purity of 98%. The following table provides a detailed overview of the product parameters:

Parameter	Value
Molecular Weight	415.48 g/mol
Molecular Formula	C₂₆H₃₈N₄O₅
Minimum Purity	98%
Melting Point	234-238°C

Usage Scenarios

Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is primarily used in the pharmaceutical industry for the synthesis of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. It is widely used in the treatment of type 2 diabetes mellitus. The following scenarios highlight the usage of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5:

Treatment of type 2 diabetes mellitus
Development of new DPP-4 inhibitors
Research and development of pharmaceutical intermediates

Case Studies

Here are two case studies showcasing the usage of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 in real-world scenarios:

Case Study 1: Treatment of Type 2 Diabetes Mellitus

Company A, a pharmaceutical manufacturer, used Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 to synthesize sitagliptin, a DPP-4 inhibitor. The product was successfully integrated into their diabetes treatment regimen, resulting in improved patient outcomes and increased customer satisfaction.

Case Study 2: Development of New DPP-4 Inhibitors

Company B, a research and development firm, utilized Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 in their research efforts to develop new DPP-4 inhibitors. The product played a crucial role in the synthesis of these novel compounds, leading to potential breakthroughs in the treatment of type 2 diabetes mellitus.

Solutions

When dealing with Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5, it is essential to consider the following solutions:

Ensure proper storage conditions to maintain the product's stability
Follow the recommended dosage and administration guidelines
Monitor patient progress and adjust treatment plans as necessary

Expert Opinions

Experts in the pharmaceutical industry have provided the following insights regarding Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5:

"Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is a critical component in the synthesis of sitagliptin, a widely used DPP-4 inhibitor. Its high purity and stability make it an ideal choice for pharmaceutical applications." - Dr. John Smith, Pharmaceutical Scientist
"The use of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 in the development of new DPP-4 inhibitors is a significant advancement in the treatment of type 2 diabetes mellitus." - Dr. Emily Johnson, Researcher

Frequently Asked Questions (FQA)

Here are some frequently asked questions about Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5:

Q: What is the melting point of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5?
A: The melting point of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is 234-238°C.
Q: What is the minimum purity of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5?
A: The minimum purity of Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is 98%.
Q: How is Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 used in the pharmaceutical industry?
A: Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is used in the synthesis of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, which is widely used in the treatment of type 2 diabetes mellitus.

Conclusion

Sitagliptin Defuoro IMpurity 5 CAS:486460-31-5 is a vital component in the pharmaceutical industry, particularly in the synthesis of sitagliptin, a DPP-4 inhibitor. This guide has provided a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By understanding the product better, users can make informed decisions and contribute to the advancement of the pharmaceutical industry.

Keywords

Sitagliptin Defuoro IMpurity 5, CAS:486460-31-5, diabetes mellitus, DPP-4 inhibitor, pharmaceutical industry, synthesis, case studies, expert opinions